Brief: Cannara Biotech Posts Q2 Net Revenue Of $13 Mln
April 24 (Reuters) - Lovesac Co LOVE.O :
* CANNARA BIOTECH INC. REPORTS Q2 2023 FINANCIAL RESULTS
WITH
QUARTERLY NET REVENUES OF $13 MILLION, A 76% INCREASE COMPARED
TO Q2 2022
* CANNARA BIOTECH INC - Q2 2023 NET REVENUE OF $13 MILLION
* CANNARA BIOTECH INC - COMPANY HAS $25.6 MILLION IN WORKING
CAPITAL AS OF FEBRUARY 28, 2023, WHICH INCLUDES $4.1 MILLION OF
CASH ON HAND
Source text for Eikon: ID:nCNW6f7PVa
Further company coverage: LOVE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cannara Biotech
See all newsCanada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Brief: Cannara Biotech Q4 EPS CAD 0.04